NATURE QUEEN Trademark

Trademark Overview


On Tuesday, July 25, 2017, a trademark application was filed for NATURE QUEEN with the United States Patent and Trademark Office. The USPTO has given the NATURE QUEEN trademark a serial number of 87540974. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Tuesday, August 19, 2025. This trademark is owned by SUNSTAR JOINT STOCK COMPANY. The NATURE QUEEN trademark is filed in the Pharmaceutical Products category with the following description:

[ Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; ] Pharmaceutical preparations for the treatment of musculo-skeletal disorders; [ Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of worms in pets; ] Pharmaceutical preparations for the treatment of infectious diseases; [ Pharmaceutical preparations for the treatment of heart rhythm disorders; ] Pharmaceutical preparations for the treatment of kidney diseases; [ Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of hormonal disorders ] and the prevention of osteoporosis; [ Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for the treatment of immune syste...
nature queen

General Information


Serial Number87540974
Word MarkNATURE QUEEN
Filing DateTuesday, July 25, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateTuesday, August 19, 2025
Registration Number5591356
Registration DateTuesday, October 23, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2017

Trademark Statements


Goods and Services[ Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; ] Pharmaceutical preparations for the treatment of musculo-skeletal disorders; [ Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of worms in pets; ] Pharmaceutical preparations for the treatment of infectious diseases; [ Pharmaceutical preparations for the treatment of heart rhythm disorders; ] Pharmaceutical preparations for the treatment of kidney diseases; [ Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of hormonal disorders ] and the prevention of osteoporosis; [ Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; ] Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; [ Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, ] blood disorders, pain, inflammation, [ sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, ] kidney diseases or disorders, [ and diabetes; ] Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; [ Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine,] musculoskeletal, cardiovascular, [ cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, ] neurological, gastrointestinal, [ hormonal, dermatological, psychiatric and immune system related diseases and disorders; ] Herbal supplements;[ Dietary supplements; ] Nutritional supplements [ ; Medicated soap; Disinfectant soap ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 29, 2017
Primary Code005
First Use Anywhere DateMonday, April 2, 2018
First Use In Commerce DateMonday, April 2, 2018

Trademark Owner History


Party NameSUNSTAR JOINT STOCK COMPANY
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressHanoi 100000
VN

Party NameSUNSTAR JOINT STOCK COMPANY
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressHanoi 100000
VN

Party NameSUNSTAR JOINT STOCK COMPANY
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressHanoi 100000
VN

Trademark Events


Event DateEvent Description
Monday, October 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 28, 2017NEW APPLICATION ENTERED
Saturday, July 29, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 23, 2017ASSIGNED TO EXAMINER
Wednesday, November 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 30, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, August 28, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 18, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 19, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 5, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 30, 2018USE AMENDMENT FILED
Tuesday, August 28, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 23, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, March 20, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 20, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 20, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 18, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 18, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 18, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 18, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 18, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 22, 2025TEAS SECTION 8 RECEIVED
Wednesday, August 6, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 19, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, August 19, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, April 18, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED